Table 2 Univariate and multivariate analysis of OS in 43 patients treated up-front with VTD.
n | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
OS @ 36 months | p-value | HR (95% CI) | p-value | |||
Gender | male | 30 | 63.3 | 0.12 | ||
female | 13 | 43.3 | ||||
ISS | I-II | 24 | 75.0 | 0.01 | 1.5 (0.5–4.3) | 0.40 |
III | 19 | 31.6 | ||||
FISH risk | standard | 38 | 60.0 | 0.74 | ||
high | 5 | 52.2 | ||||
Hb < 10 g/dL | no | 11 | 81.8 | 0.05 | ||
yes | 32 | 46.2 | ||||
LDH > 2 UPN | no | 28 | 89.7 | 0.0004 | 1.7 (0.7–3.9) | 0.21 |
yes | 15 | 39.5 | ||||
Histotype | IgG | 36 | 75.0 | 0.82 | ||
IgA | 4 | 52.5 | ||||
ClCr | <30 ml/min | 8 | 53.9 | 0.78 | ||
>30 ml/min | 35 | 62.5 | ||||
CD64 MFI on CD15 + cells | normal | 28 | 71.1 | 0.004 | 2.3 (0.9–5.8) | 0.07 |
high | 15 | 26.7 | ||||
CD16 MFI on CD15 + cells | normal | 24 | 66.7 | 0.46 | ||
low | 17 | 41.2 | ||||